Cambridge, United Kingdom

Emiliano Tamanini

USPTO Granted Patents = 13 


 

Average Co-Inventor Count = 12.3

ph-index = 5

Forward Citations = 53(Granted Patents)


Company Filing History:


Years Active: 2015-2025

Loading Chart...
Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Emiliano Tamanini

Introduction:

Emiliano Tamanini, a renowned inventor, has made significant contributions to the field of pharmaceuticals through his groundbreaking patents. Based in Cambridge, GB, Tamanini has a notable track record in inventing novel bicyclic heterocycle compounds for therapeutic applications.

Latest Patents:

Tamanini's latest patents revolve around bicyclic heterocycle compounds and their uses in therapy, particularly in the treatment of diseases like cancer. These compounds, as per the patent descriptions, hold promise in the development of pharmaceutical compositions aimed at combating various ailments.

Career Highlights:

With an impressive portfolio of 11 patents to his name, Emiliano Tamanini has demonstrated a keen understanding of medicinal chemistry and drug discovery. His work reflects a commitment to innovation and a passion for improving healthcare outcomes through cutting-edge research in the pharmaceutical sector.

Collaborations:

Throughout his career, Tamanini has collaborated with leading companies such as Astex Therapeutics Limited and Cancer Research Technology Limited. His partnerships with industry experts like Steven Howard and Ildiko Maria Buck have further enhanced the scope and impact of his inventions in the field of healthcare.

Conclusion:

Emiliano Tamanini's inventive prowess and dedication to advancing pharmaceutical science have earned him a well-deserved place among the pioneers of therapeutic innovation. His patents stand as testaments to his vision and expertise in developing novel compounds for the betterment of medical treatments globally.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…